돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1668064생성일: 2026년 10월 24일

Dimethylformamide → N-{2-chloro-5-[(2-{[(2-methylcyclopropyl)carbonyl]amino}imidazo[1,2-b]pyridazin-6-yl)oxy]phenyl}-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide

https://huagongshe.com/ko/reaction/1668064

반응식

참여 물질

역할이름HCID투입량
반응물DimethylformamideHCID 6228—
반응물Oxalyl chlorideHCID 65578—
반응물3-ethyl-1-methyl-1H-pyrazole-5-carboxylic acidHCID 820565—
반응물N-[6-(3-amino-4-chlorophenoxy)imidazo[1,2-b]pyridazin-2-yl]-2-methylcyclopropanecarboxamideHCID 57505474—
용매TetrahydrofuranHCID 8028—
용매DimethylacetamideHCID 31374—
생성물N-{2-chloro-5-[(2-{[(2-methylcyclopropyl)carbonyl]amino}imidazo[1,2-b]pyridazin-6-yl)oxy]phenyl}-3-ethyl-1-methyl-1H-pyrazole-5-carboxamideHCID 5750561350%

반응 단계

Using 3-ethyl-1-methyl-1H-pyrazole-5-carboxylic acid (181 mg, 1.17 mmol), tetrahydrofuran (4.5 mL), N,N-dimethylformamide (30 μL, 0.39 mmol), oxalyl chloride (102 μL, 1.17 mmol), N-[6-(3-amino-4-chlorophenoxy)imidazo[1,2-b]pyridazin-2-yl]-2-methylcyclopropanecarboxamide (300 mg, 0.84 mmol) and N,N-dimethylacetamide (6.0 mL), and in the same manner as in Example 249, the title compound (207 mg, 50%) was obtained as a white powder.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08044049B2
출처 데이터셋uspto-grants-2011_10
ORD IDord-051f1c9f80e94799843d2731c52a11b5
출처 메모uspto-grants-2011_10